ÀÌ·± ÀÏÀ» ÇÕ´Ï´Ù.

´ã´ç¾÷¹« ¹× ¿ªÇÒ
Pipeline / Product / Platform TechnologyÀÇ µµÀÔ ÃßÁø Èĺ¸ ¹ß±¼, ºÐ¼®, Æò°¡
  • CNS(ÁßÃ߽Űæ°è) ¹× Ç×¾ÏÁ¦(Oncology) ºÐ¾ßÀÇ µµÀÔ ÃßÁø Èĺ¸ Asset(pipeline ¹× product) and/or ±â¹Ý ±â¼úÀÇ Å½»ö ¹× ¹ß±¼(Screening/Scouting)
  • À¯°ü ºÎ¼­µé°úÀÇ Çù¾÷À» ÅëÇÑ »ó¼¼ °ËÅä(Due Diligence) ¹× Æò°¡(Evaluation) ¼öÇà
Partnering(Licensing Out)
  • SKBP º¸À¯ pipeline(Clinical or Pre-Clinical)ÀÇ ÆÄÆ®³Ê¸µ ÃßÁø Áغñ ÀÛ¾÷ – Non-confidential/Confidential Data Package ÀÛ¼º ¹× eDD room ±¸¼º/°ü¸® µî
  • Potential Customer Ž»ö, ¼±º° ¹× Á¢ÃË, DD ´ëÀÀ, ÆÄÆ®³Ê¸µ term ÀÛ¼º ¹× °è¾à ü°á ÃßÁø
Pharmaceutical Market ¹× Business ȯ°æÀÇ Intelligence ¹× Insight È®º¸
  • ¹ÙÀÌ¿À¡¤Á¦¾à ¾÷°èÀÇ Business(deal, ÆÄÆ®³Ê¸µ µî) events¿¡ ´ëÇÑ ½ÉÃþ Á¶»ç/ºÐ¼® ¼öÇà
  • ¹ÙÀÌ¿À¡¤Á¦¾à ¾÷°èÀÇ Áß¿ä °á°ú ¹ßÇ¥ eventµé(ÀÓ»ó °á°ú ¹× °¢Á¾ impact ÀÖ´Â study °á°ú ¹ßÇ¥ µî)¿¡ ´ëÇÑ ºÐ¼®/Æò°¡ º¸°í¼­ ÀÛ¼º – Insight Á¦°ø
  • À¯¸Á compound µîÀÇ ÀÓ»ó/ÀüÀÓ»ó data¸¦ ºÐ¼®ÇÏ¿© »ç¾÷ Àü·«¿¡ Ȱ¿ë °¡´ÉÇÑ Insight Á¦°ø
  • Àü»ç Àü·«°ú alignedµÈ ÁÖ¿ä indication/therapeutic area¿¡ ´ëÇÑ landscape report ¹ß°£
°æ¿µÁø º¸°í ÀÚ·á ÀÛ¼º
  • µµÀÔ ÃßÁø Èĺ¸ÀÇ ¹ß±¼/ÃßÁø °¡´É¼º Æò°¡, ºÐ¼® º¸°í¼­ ÀÛ¼º
  • ÇÊ¿ä ½Ã ÆÄÆ®³Ê¸µ activity¿¡ ´ëÇÑ °èȹ, °á°ú, ÇöȲ µî¿¡ ´ëÇÑ º¸°í¼­ ÀÛ¼º

ÀÌ·± ºÐ°ú ÇÔ²² ÇÏ°í ½Í½À´Ï´Ù.

Áö¿øÀÚ°Ý
  • Çз : Çлç ÀÌ»ó
  • Àü°ø : »ý¸í°úÇÐ, ¾àÇÐ, »ý¹°ÇÐ µî Á¦¾à/¹ÙÀÌ¿À °ü·Ã Àü°ø
  • ¿µ¾î ¸»ÇÏ±â ¹× ¾²±â ´É·ÂÀÌ ¿ì¼öÇϸç, ±Û·Î¹ú ȯ°æ¿¡¼­ È¿°úÀûÀ¸·Î Ä¿¹Â´ÏÄÉÀ̼ÇÇÒ ¼ö ÀÖ´Â ºÐ

ÀÌ·± °æÇèÀÌ ÀÖ´Ù¸é ´õ ȯ¿µÇÕ´Ï´Ù.

¿ì´ë»çÇ×
  • CNS/Oncology ¿¬±¸ °æ·Â ¹× ÀÓ»ó ¼öÇà °æ·Â º¸À¯ÀÚ
  • Á¦¾à ¶Ç´Â ÇコÄɾî ȸ»ç Business Development ¶Ç´Â Licensing In/Out ºÎ¼­ ±Ù¹« °æ·Â º¸À¯ÀÚ
  • Á¦¾à ¶Ç´Â ÇコÄÉ¾î »ê¾÷¿¡¼­ÀÇ ½ÃÀå ¹× °æÀï»ç/Compound/Pipeline/Product ºÐ¼® °æÇè º¸À¯ÀÚ
  • ´Ù¾çÇÑ ¾÷¹«¸¦ ¿ì¼±¼øÀ§¿¡ µû¶ó ó¸®Çϸç Á¤ÇØÁø ±âÇÑ ³»¿¡ °á°ú¸¦ µµÃâÇÑ °æÇè º¸À¯ÀÚ
  • µ¥ÀÌÅÍ ºÐ¼® (GlobalData, EvaluatePharma µî Database ±â¹Ý) ¹× ÇÁ·¹Á¨Å×ÀÌ¼Ç µµ±¸ (Excel, PowerPoint µî) »ç¿ë ´É¼÷ÀÚ
  • ±Û·Î¹ú ÄÁÆÛ·±½º/³×Æ®¿öÅ·/ÆÄÆ®³Ê¸µ °æÇè(BIO, JP Morgan Health Conference µî) º¸À¯ÀÚ

ÀÌ·¯ÇÑ ¿©Á¤À¸·Î ÁøÇàµË´Ï´Ù.

ÀüÇüÀýÂ÷
»ó¼¼ÀÏÁ¤
  • ¼­·ù Á¢¼ö : ~2/26
  • ÇÊ±â ¹× ¸éÁ¢ ÀüÇü : »ó¼¼ÀÏÁ¤ °³º° ¾È³»

¹Ì¸® È®ÀÎÇØ ÁÖ¼¼¿ä.

±Ù¹«Áö
  • °æ±âµµ ÆÇ±³
±âŸ»çÇ×
  • ±¹°¡ º¸ÈÆ ´ë»óÀÚ ¹× Àå¾ÖÀÎÀº °ü·Ã¹ý¿¡ ÀǰŠ¿ì´ëÇÕ´Ï´Ù.
  • ¼®,¹Ú»ç ÇÐÀ§ ¼ÒÁöÀÚÀÇ °æ¿ì Çл縦 Æ÷ÇÔÇÑ Àüü Çз Á¤º¸¸¦ ±âÀÔÇØ Áֽñ⠹ٶø´Ï´Ù.
  • ½áÄ¡Æß°ú SK Careers Æ÷ÅÐ Áߺ¹ Áö¿øÀº ºÒ°¡´É ÇÕ´Ï´Ù.
  • ´ç»ç ä¿ë °ø°í °£ Áߺ¹ Áö¿øÀº ºÒ°¡´É ÇÕ´Ï´Ù.
  • °¢ ÀüÇü ÀÏÁ¤Àº »óȲ¿¡ µû¶ó Á¶Á¤µÉ ¼ö ÀÖ½À´Ï´Ù.
  • º´¿ªÇÊ ¶Ç´Â ¸éÁ¦ÀÚ(³²¼ºÀÇ °æ¿ì)·Î¼­ ÇØ¿Ü ¿©Çà¿¡ °á°Ý »çÀ¯°¡ ¾ø´Â ºÐ¿¡ ÇÑÇÏ¿© Áö¿øÀÌ °¡´ÉÇÕ´Ï´Ù.